UC  IS  OVERWHELMING
TREATMENT  SHOULDN’T  BE

The injection experience she wants, proven efficacy she needs12

The person depicted 
is a model used 
for illustrative 
purposes only.

Most common adverse reactions are upper respiratory tract infection, nasopharyngitis, and injection-site reactions.

Reference: 1. SIMPONI® (golimumab) Prescribing Information. Janssen Biotech, Inc.
Reference: 1. Data on file. Janssen Biotech, Inc.